GHC vs. APYX

Last updated Apr 1, 2026

Compare and contrast key facts about Graham Holdings Company (GHC) and Apyx Medical Corporation (APYX).

Performance

GHC vs. APYX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Graham Holdings Company (GHC) and Apyx Medical Corporation (APYX). The values are adjusted to include any dividend payments, if applicable.

GHC vs. APYX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
GHC Graham Holdings Company	-3.61%	26.98%	26.32%	16.56%	-3.02%	19.25%	-15.32%	-1.32%
APYX Apyx Medical Corporation	5.43%	121.52%	-39.69%	11.97%	-81.75%	78.06%	-14.89%	26.46%

Fundamentals

Market Cap GHC : $4.62B APYX : $155.58M
EPS GHC : $66.81 APYX : -$0.27
PB Ratio GHC : 0.96 APYX : 10.70
Total Revenue (TTM) GHC : $0.00 APYX : $52.10M
Gross Profit (TTM) GHC : $0.00 APYX : $33.04M
EBITDA (TTM) GHC : $752.94M APYX : -$5.09M

Returns By Period

In the year-to-date period, GHC achieves a -3.61% return, which is significantly lower than APYX's 5.43% return.

GHC

• 1D: 0.71%
• 1M: 0.38%
• YTD: -3.61%
• 6M: -9.88%
• 1Y: 10.86%
• 3Y*: 22.16%
• 5Y*: 14.07%
• 10Y*: 9.09%

APYX

• 1D: 3.07%
• 1M: 12.84%
• YTD: 5.43%
• 6M: 72.43%
• 1Y: 169.34%
• 3Y*: 8.61%
• 5Y*: -17.68%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

GHC vs. APYX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GHC

GHC Risk / Return Rank: 53
GHC Sharpe Ratio Rank: 56
GHC Sortino Ratio Rank: 49
GHC Omega Ratio Rank: 48
GHC Calmar Ratio Rank: 56
GHC Martin Ratio Rank: 57

APYX

APYX Risk / Return Rank: 88
APYX Sharpe Ratio Rank: 87
APYX Sortino Ratio Rank: 88
APYX Omega Ratio Rank: 83
APYX Calmar Ratio Rank: 94
APYX Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GHC vs. APYX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Graham Holdings Company (GHC) and Apyx Medical Corporation (APYX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GHC	APYX	Difference
Sharpe ratio Return per unit of total volatility	0.39	1.65	-1.26
Sortino ratio Return per unit of downside risk	0.73	2.64	-1.91
Omega ratio Gain probability vs. loss probability	1.09	1.31	-0.22
Calmar ratio Return relative to maximum drawdown	0.60	5.05	-4.46
Martin ratio Return relative to average drawdown	1.49	11.31	-9.82
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GHC vs. APYX - Sharpe Ratio Comparison

The current GHC Sharpe Ratio is 0.39, which is lower than the APYX Sharpe Ratio of 1.65. The chart below compares the historical Sharpe Ratios of GHC and APYX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	GHC	APYX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.39	1.65	-1.26
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.54	-0.18	+0.72
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.32	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.27	-0.09	+0.35

Correlation

The correlation between GHC and APYX is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

GHC vs. APYX - Dividend Comparison

GHC's dividend yield for the trailing twelve months is around 0.69%, while APYX has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
GHC Graham Holdings Company	0.69%	0.66%	0.79%	0.95%	1.05%	0.96%	1.09%	0.87%	0.83%	0.91%	0.95%	89.61%
APYX Apyx Medical Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

GHC vs. APYX - Drawdown Comparison

The maximum GHC drawdown since its inception was -67.54%, smaller than the maximum APYX drawdown of -94.99%. Use the drawdown chart below to compare losses from any high point for GHC and APYX.

Drawdown Indicators

	GHC	APYX	Difference
Max Drawdown Largest peak-to-trough decline	-67.54%	-94.99%	+27.45%
Max Drawdown (1Y) Largest decline over 1 year	-19.78%	-32.17%	+12.39%
Max Drawdown (5Y) Largest decline over 5 years	-21.36%	-94.99%	+73.63%
Max Drawdown (10Y) Largest decline over 10 years	-62.55%	—	—
Current Drawdown Current decline from peak	-11.29%	-78.79%	+67.50%
Average Drawdown Average peak-to-trough decline	-19.38%	-56.43%	+37.05%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.90%	16.25%	-8.35%

Volatility

GHC vs. APYX - Volatility Comparison

The current volatility for Graham Holdings Company (GHC) is 6.60%, while Apyx Medical Corporation (APYX) has a volatility of 25.51%. This indicates that GHC experiences smaller price fluctuations and is considered to be less risky than APYX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GHC	APYX	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.60%	25.51%	-18.91%
Volatility (6M) Calculated over the trailing 6-month period	20.76%	55.45%	-34.69%
Volatility (1Y) Calculated over the trailing 1-year period	28.11%	103.25%	-75.14%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.23%	98.94%	-72.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.25%	93.04%	-64.79%

Financials

GHC vs. APYX - Profitability Comparison

The chart below illustrates the profitability comparison between Graham Holdings Company and Apyx Medical Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

GHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Graham Holdings Company reported a gross profit of -1.10B and revenue of -3.66B. Therefore, the gross margin over that period was 30.0%.

APYX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Apyx Medical Corporation reported a gross profit of 12.00M and revenue of 18.42M. Therefore, the gross margin over that period was 65.2%.

GHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Graham Holdings Company reported an operating income of 47.59M and revenue of -3.66B, resulting in an operating margin of -1.3%.

APYX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Apyx Medical Corporation reported an operating income of 11.00K and revenue of 18.42M, resulting in an operating margin of 0.1%.

GHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Graham Holdings Company reported a net income of 108.72M and revenue of -3.66B, resulting in a net margin of -3.0%.

APYX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Apyx Medical Corporation reported a net income of -1.22M and revenue of 18.42M, resulting in a net margin of -6.6%.